|
|
|
|
| LEADER |
01804nam a2200601Ia 4500 |
| 001 |
10.1016-j.jiph.2020.05.009 |
| 008 |
220121s2020 CNT 000 0 und d |
| 020 |
|
|
|a 18760341 (ISSN)
|
| 245 |
1 |
0 |
|a Can complementary and alternative medicines be beneficial in the treatment of COVID-19 through improving immune system function?
|
| 260 |
|
0 |
|b Elsevier Ltd,
|c 2020
|
| 650 |
0 |
4 |
|a adaptive immunity
|
| 650 |
0 |
4 |
|a Adaptive Immunity
|
| 650 |
0 |
4 |
|a alternative medicine
|
| 650 |
0 |
4 |
|a amino acid sequence
|
| 650 |
0 |
4 |
|a antibody
|
| 650 |
0 |
4 |
|a antiviral activity
|
| 650 |
0 |
4 |
|a ascorbic acid
|
| 650 |
0 |
4 |
|a colecalciferol
|
| 650 |
0 |
4 |
|a Complementary Therapies
|
| 650 |
0 |
4 |
|a coronavirus disease 2019
|
| 650 |
0 |
4 |
|a Coronavirus infection
|
| 650 |
0 |
4 |
|a Coronavirus Infections
|
| 650 |
0 |
4 |
|a curcumin
|
| 650 |
0 |
4 |
|a drug megadose
|
| 650 |
0 |
4 |
|a herbaceous agent
|
| 650 |
0 |
4 |
|a human
|
| 650 |
0 |
4 |
|a Humans
|
| 650 |
0 |
4 |
|a immune system
|
| 650 |
0 |
4 |
|a Immune System
|
| 650 |
0 |
4 |
|a Immunity, Innate
|
| 650 |
0 |
4 |
|a immunology
|
| 650 |
0 |
4 |
|a innate immunity
|
| 650 |
0 |
4 |
|a Letter
|
| 650 |
0 |
4 |
|a lung alveolus macrophage
|
| 650 |
0 |
4 |
|a lymphocyte transformation
|
| 650 |
0 |
4 |
|a mineral
|
| 650 |
0 |
4 |
|a nonhuman
|
| 650 |
0 |
4 |
|a nutrition supplement
|
| 650 |
0 |
4 |
|a pandemic
|
| 650 |
0 |
4 |
|a Pandemics
|
| 650 |
0 |
4 |
|a phagocytosis
|
| 650 |
0 |
4 |
|a physiology
|
| 650 |
0 |
4 |
|a Pneumonia, Viral
|
| 650 |
0 |
4 |
|a priority journal
|
| 650 |
0 |
4 |
|a virus antigen
|
| 650 |
0 |
4 |
|a virus pneumonia
|
| 650 |
0 |
4 |
|a vitamin
|
| 856 |
|
|
|z View Fulltext in Publisher
|u https://doi.org/10.1016/j.jiph.2020.05.009
|
| 700 |
1 |
0 |
|a Akbari, E.
|e author
|
| 700 |
1 |
0 |
|a Nilashi, M.
|e author
|
| 700 |
1 |
0 |
|a Samad, S.
|e author
|
| 700 |
1 |
0 |
|a Yusuf, S.Y.M.
|e author
|
| 773 |
|
|
|t Journal of Infection and Public Health
|x 18760341 (ISSN)
|g 13 6, 893-896
|
